- Home
- GALT vs VLYPO Comparison
GALT vs VLYPO Comparison
Compare GALT & VLYPO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GALT
- VLYPO
- Stock Information
- Founded
- GALT 2000
- VLYPO N/A
- Country
- GALT United States
- VLYPO United States
- Employees
- GALT N/A
- VLYPO 3749
- Industry
- GALT Biotechnology: Pharmaceutical Preparations
- VLYPO Major Banks
- Sector
- GALT Health Care
- VLYPO Finance
- Exchange
- GALT Nasdaq
- VLYPO Nasdaq
- Market Cap
- GALT 147.8M
- VLYPO N/A
- IPO Year
- GALT N/A
- VLYPO N/A
- Fundamental
- Price
- GALT $1.04
- VLYPO $24.92
- Analyst Decision
- GALT Strong Buy
- VLYPO
- Analyst Count
- GALT 1
- VLYPO 0
- Target Price
- GALT $11.00
- VLYPO N/A
- AVG Volume (30 Days)
- GALT 1.1M
- VLYPO N/A
- Earning Date
- GALT 11-13-2024
- VLYPO N/A
- Dividend Yield
- GALT N/A
- VLYPO N/A
- EPS Growth
- GALT N/A
- VLYPO N/A
- EPS
- GALT N/A
- VLYPO N/A
- Revenue
- GALT N/A
- VLYPO N/A
- Revenue This Year
- GALT N/A
- VLYPO N/A
- Revenue Next Year
- GALT N/A
- VLYPO N/A
- P/E Ratio
- GALT N/A
- VLYPO N/A
- Revenue Growth
- GALT N/A
- VLYPO N/A
- 52 Week Low
- GALT $0.73
- VLYPO N/A
- 52 Week High
- GALT $4.27
- VLYPO N/A
- Technical
- Relative Strength Index (RSI)
- GALT 20.80
- VLYPO 40.64
- Support Level
- GALT $1.80
- VLYPO $24.57
- Resistance Level
- GALT $2.36
- VLYPO $25.52
- Average True Range (ATR)
- GALT 0.27
- VLYPO 0.19
- MACD
- GALT -0.08
- VLYPO -0.06
- Stochastic Oscillator
- GALT 15.07
- VLYPO 36.84
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.
About VLYPO Valley National Bancorp 5.50% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock Series B
Valley National Bancorp is a bank holding company whose principal wholly-owned subsidiary is Valley National Bank. It provides a full range of commercial, retail, and trust and investment services largely through its offices and ATM network throughout northern and central New Jersey, New York City Long Island, Florida, and Alabama. The segments of the group are commercial lending, consumer lending, investment management, and corporate and other adjustments, of which key interest income is derived from the commercial lending segment. In recent years, the company has focused on acquiring companies that operate outside of traditional banking and has emphasized wealth and capital management.